Trials / Completed
CompletedNCT00567905
Effect of Green Tea Extract on Type 2 Diabetes
Effect of Green Tea Extract on Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Taipei Hospital, Taiwan · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effect of green tea extract (GTE) on type 2 diabetes and to explore the relationship between GTE and related hormone peptides.
Detailed description
Green tea is one of the most popular beverages in the world. It is believed to have beneficial effects in prevention and treatment of many diseases, one of which is anti-obesity and anti-diabetes. The benefit effects of green tea are mainly attributed to its polyphenol content, especially the most abundant one-epigallocatechin gallate (EGCG), which might inhibit adipocyte proliferation and differentiation in vitro studies We hypothesized that GTE would improve insulin resistance in type 2 overweight diabetes and related hormone peptides will be influenced. Thus, we conducted this randomized clinical trial to examine the effect of GTE on type 2 diabetes and to explore the relationship between GTE and related hormone peptides.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Green tea extract | main content is epigallocatechin gallate (EGCG, 58%) |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2007-12-05
- Last updated
- 2009-01-13
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00567905. Inclusion in this directory is not an endorsement.